Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography.

Journal: Scientific reports
Published Date:

Abstract

Here, we have developed a deep learning method to fully automatically detect and quantify six main clinically relevant atrophic features associated with macular atrophy (MA) using optical coherence tomography (OCT) analysis of patients with wet age-related macular degeneration (AMD). The development of MA in patients with AMD results in irreversible blindness, and there is currently no effective method of early diagnosis of this condition, despite the recent development of unique treatments. Using OCT dataset of a total of 2211 B-scans from 45 volumetric scans of 8 patients, a convolutional neural network using one-against-all strategy was trained to present all six atrophic features followed by a validation to evaluate the performance of the models. The model predictive performance has achieved a mean dice similarity coefficient score of 0.706 ± 0.039, a mean Precision score of 0.834 ± 0.048, and a mean Sensitivity score of 0.615 ± 0.051. These results show the unique potential of using artificially intelligence-aided methods for early detection and identification of the progression of MA in wet AMD, which can further support and assist clinical decisions.

Authors

  • Wei Wei
    Dept. Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Joshua Southern
    Computing, Imperial College London, London, UK.
  • Kexuan Zhu
    Ningbo Medical Center Lihuili Hospital, Ningbo, China.
  • Yefeng Li
    School of Cyber Science and Engineering, Ningbo University of Technology, Ningbo, China.
  • Maria Francesca Cordeiro
    UCL Institute of Ophthalmology, London, United Kingdom; Novai Ltd, Reading, United Kingdom; Imperial College Ophthalmology Research Group, Imperial College London, London, United Kingdom. Electronic address: m.cordeiro@ucl.ac.uk.
  • Kirill Veselkov
    Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.